Laurent Eckert

12.4k citations
101 papers · 9.9k · 10 hit papers · h-index 43

Impact in

  • Dermatology top 0.01%
    • Dermatology and Skin Diseases
    • Contact Dermatitis and Allergies
    • Allergic Rhinitis and Sensitization
    • Food Allergy and Anaphylaxis Research

Papers in

Laurent Eckert

97 papers receiving 9.6k citations

Laurent Eckert's Hit Papers

Atopic dermatitis in the pediatric population 2021 · 316 citations
3160+3+6Years since publication50010001.5k

Peers

Laurent Eckert
Comparison fields: 5 of 114
  • Dermatology 7.0k
  • Immunology and Allergy 3.4k
  • Physiology 2.6k
  • Otorhinolaryngology 315
  • Rheumatology 1.1k
Replace Abhijit S. Gadkari with:
Abhijit S. Gadkari United States
Heribert W. Staudinger United States
Yuji Tohda Japan
Camille Taillé France
Pierluigi Paggiaro Italy
Néstor A. Molfino United States
David A. Mathison United States
Lars Söderström Sweden
Iris Hiu-Shuen Chan Hong Kong
Irvin Mayers Canada
Laurent Eckert relative to Abhijit S. Gadkari United States Abhijit S. Gadkari's profile →
Citations per field
00.5×2×3×3.6×
Abhijit S. Gadkari · 1×
Citations per year

Countries citing papers authored by Laurent Eckert

Since Specialization
Citations

This map shows the geographic impact of Laurent Eckert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Eckert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Eckert more than expected).

Fields of papers citing papers by Laurent Eckert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Eckert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Eckert. The network helps show where Laurent Eckert may publish in the future.

Co-authors

The 25 scholars most cited alongside Laurent Eckert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Laurent Eckert Line = papers co-authored together Laurent Eckert links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Hit paper breakdown →
20161703
2
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
Hit paper breakdown →
20171037
3
Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
Hit paper breakdown →
2016751
4
Epidemiology of atopic dermatitis in adults: Results from an international survey
Hit paper breakdown →
2018660
5
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis
Hit paper breakdown →
2019416
6
Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t
Hit paper breakdown →
2017412
7
Atopic dermatitis in the pediatric population
Hit paper breakdown →
2021316
8
Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate‐to‐severe atopic dermatitis
Hit paper breakdown →
2019293
9
Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults
Hit paper breakdown →
2016256
10
Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study
Hit paper breakdown →
2019213
11 2011202
12 2017189
13 2019171
14 2013168
15 2019159
16 2019156
17 2018152
18 2016139
19 2018122
20 2019121

About Laurent Eckert

Laurent Eckert is a scholar working on Dermatology, Immunology and Allergy, Physiology, Rheumatology and Immunology, having authored 101 papers that have together received 9.9k indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (74 papers), Asthma and respiratory diseases (28 papers), Allergic Rhinitis and Sensitization (15 papers), Urticaria and Related Conditions (8 papers), Food Allergy and Anaphylaxis Research (7 papers), IL-33, ST2, and ILC Pathways (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). The work is most often cited by research in Dermatology (7.0k citations), Immunology and Allergy (3.4k citations), Physiology (2.6k citations), Otorhinolaryngology (315 citations) and Rheumatology (1.1k citations). Laurent Eckert has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Neil M.H. Graham, Gianluca Pirozzi, Abhijit S. Gadkari, Ameya Gadkari, Eric Lawrence Simpson, Sebastien Barbarot, Marjolein S. de Bruin-Weller, Eric Lawrence Simpson, Sébastien Auzière and Marius Ardeleanu. Their work appears in journals such as Journal of the American Academy of Dermatology, British Journal of Dermatology, Journal of Allergy and Clinical Immunology, Dermatology and Therapy and Journal of Dermatological Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact